Cocrystal Pharma, Inc. - Common Stock, par value $0.001 per share (COCP)

Historical Holders from Q4 2022 to Q3 2025

Symbol
COCP on Nasdaq
Type / Class
Equity / Common Stock, par value $0.001 per share
Shares outstanding
13,831,528
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
664,982
Holdings value
$831,248
% of all portfolios
0%
Number of holders
21
Number of buys
7
Number of sells
-9
Average buys %
+0%
Average sells %
-0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Cocrystal Pharma, Inc. - Common Stock, par value $0.001 per share (COCP)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
FROST PHILLIP MD ET AL 17.8% +65.5% $3,078,992 +$1,349,571 2,462,012 +78% Phillip Frost, M.D. 28 Oct 2025

Institutional Holders of Cocrystal Pharma, Inc. - Common Stock, par value $0.001 per share (COCP)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 664,982 $831,248 -$40,108 $1.25 21
2025 Q2 686,516 $1,022,928 -$87,903 $1.49 21
2025 Q1 748,773 $1,064,069 +$47,078 $1.42 23
2024 Q4 711,389 $1,437,038 -$15,989 $2.02 23
2024 Q3 719,274 $1,265,944 +$79,057 $1.76 19
2024 Q2 674,355 $1,571,278 -$90,505 $2.33 13
2024 Q1 721,322 $1,013,555 +$53,963 $1.4 14
2023 Q4 683,341 $1,173,672 -$35,542 $1.72 16
2023 Q3 704,225 $1,316,878 +$61,523 $1.87 15
2023 Q2 666,895 $1,594,259 -$144,985 $2.39 19
2023 Q1 738,638 $1,468,069 -$651,598 $1.99 19
2022 Q4 1,065,912 $2,076,645 +$2,076,610 $1.95 18